Statistics for investigation of multimodal MR imaging data and an application to multiple sclerosis patients

NMR in Biomedicine

Volumn 9, Issue 8, 1996, Pages 339-346

  Fu, L ^a,b   Wolfson, C ^b   Worsley, K J ^b   De Stefano, N ^a   Collins, D L ^a   Narayanan, S ^a   Arnold, D L ^a  

^a MCGILL UNIVERSITY   (Canada)

^b Dept of Epidemiol and Biostatist ^*  (Canada)

Author keywords

Axonal damage; Magnetic resonance spectroscopy; Multimodal analysis; Multiple sclerosis; Statistical methods

Indexed keywords

ASPARTIC ACID; CREATINE; DRUG DERIVATIVE; N ACETYLASPARTIC ACID; N-ACETYLASPARTATE;

ARTICLE; BRAIN; COMPUTER ASSISTED DIAGNOSIS; DISEASE COURSE; HUMAN; METABOLISM; METHODOLOGY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; RECURRENT DISEASE; REFERENCE VALUE; THEORETICAL MODEL;

ASPARTIC ACID; BRAIN; CREATINE; DISEASE PROGRESSION; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MODELS, THEORETICAL; MULTIPLE SCLEROSIS; RECURRENCE; REFERENCE VALUES;

EID: 0030437628     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(199612)9:8<339::AID-NBM422>3.0.CO;2-X     Document Type: Article

References (28)

1. Moffett, J. R., Namboordiri, M. A. A., Cangro, C. B. and Neale, J. H. Immunohistochemical localization of N-acetyl-aspartate in rat brain. NeuroReport 2(3), 131-134 (1991).
2. Simmons, M. L., Frondoza, C. G. and Coyle, J. T. Immunonistochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45(1), 37-45 (1991).
3. Arnold, D. L., Matthews, P. M., Francis, G. and Antel, J. P. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn. Reson. Med. 14, 154-159 (1990).
4. Larsson, H. B. W., Christiansen, P., Jensen, M., Frederiksen, J., Heltberg, A., Olesen, J. and Henriksen, O. Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis. Magn. Reson. Med. 22, 23-31 (1991).
5. Matthew, P. M., Francis, G., Antel, J. and Arnold, D. L. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 41, 1251-1256 (1991).
6. Miller, D. H., Austin, S. J., Connelly, A., Youl, D. B., Gadian, D. G. and McDonald, W. I. Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis. Lancet 337, 58 (1991).
7. Narayana, P. A., Wolinsky, J. S., Jackson, E. F. and McCarthy, M. Proton MR spectroscopy of gadolinium enhanced multiple sclerosis plaques. J. Magn. Reson. Imag. 2, 263-270 (1992).
8. 1H magnetic resonance spectroscopic imaging. Neurology 43, A182 (1993).
9. Collins, D. L., Fu, L., Pioro, P., Evans, A. C. and Arnold, D. L. Generation of normal average metabolite images from MRSI in stereotaxic space. Proceedings of the Society of Magnetic Resonance in Medicine. Abstr., p. 1536 (1993).
10. Arnold, D. L., Pioro, E., Fu, L., Narayanan, S., Francis, G. and Antel, J. P. Spatial distribution of abnormalities on MRI and MRSI in multiple sclerosis. Proceedings of the Society of Magnetic Resonance in Medicine. Abstr., p. 282 (1993).
11. Laird, N. M. and Ware, J. H. Random-effects models for longitudinal data. Biometrics 83, 963-974 (1982).
12. Ordidge, R. J., Mansfield, P., Lohman, J. A. and Prime, S. B. Volume selection using gradients and selective pulses. Ann. NY Acad. Sci. 508, 376-385 (1987).
13. 31P NMR spectroscopy. Magn. Reson. Med. 11, 1-21 (1989).
14. 1H NMR spectroscopic imaging. Proceedings of the Society of the Magnetic Resonance in Medicine. Abstr., p. 472 (1991).
15. Roth, K., Kimber, B. J. and Feeney, J. Data shift accumulation and alternate delay accumulation techniques for overcoming dynamic range problems. J. Magn. Reson. 41, 302 (1980).
16. Kamber, M. Automated detection of multiple sclerosis lesions in magnetic resonance images of the human brain. Master's Thesis, Concordia University, Montreal (1991).
17. Talairach, J. and Tournoux, P. Co-planar Stereotactic Atlas of the Human Brain: Three-dimensional System: an Approach to Cerebral Imaging. Georg Thieme, Stuttgart (1988).
18. Evans, A. C., Marrett, S., Neelin, P. et al. Anatomical mapping of functional activation in Stereotactic coordinate space. NeuroImage 1, 43-63 (1992).
19. Kleinbaum, D., Kupper, L. and Muller, K. Applied Regression Analysis and Other Multivariable Methods, 2nd ed. PWS-Kent (1988).
20. Rubin, D. B. Inference and missing data. Biometrika 63, 581-592 (1976).
21. Little, R. J. A. and Rubin, D. B. Statistical Analysis with Missing Data. Wiley, New York (1987).
22. Friston, K. J., Holmes, A. P., Proline, J.-B. et al. Analysis of fMRI time-series revisited. Neuroimage 2, 45-53 (1995).
23. Jenrich, R. and Schluchter, M. D. Unbalanced repeated-measures models with structured covariance matrices. Biometrics 42, 805-820 (1986).
24. Kurtzke, J. F. Rating neurological impairment in multiple sclerosis: an expanded disability status scale(EDSS). Neurology 33, 1444-1452 (1983).
25. Davie, C. A., Hawkins, C. P., Barker, G. J. et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117, 49-58 (1994).
26. De Stefano, N., Matthews, P. M. and Arnold, D. L. Reversible decrease in N-acetylaspartate after acute brain injury. Magn. Reson. Med. (in press).
27. 1H spectroscopic imaging. Ann. Neurol. 36(2), 157-165 (1994).
28. Kleinbaum, D., Kupper, L. and Muller, K. Modeling: Analysis Strategy. In Epidemiologic Research: Principles and Quantitative Methods, Chap. 21. Lifetime Learning Publications (1982).